Although genomic sequencing of tumor samples revealed occasional loss of STAG2 and CDKN2A, as well as mutations in TP53, this pediatric malignancy is largely genomically stable, suggesting that transcriptional dysregulation by EWS/FLI is the primary oncogenic driver [3-5]. The gene discussed is EWSR1; the disease is neoplasm.